SimplyRich’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$637K Buy
46,059
+3,274
+8% +$45.6K 0.16% 120
2025
Q4
$600K Buy
42,785
+14,822
+53% +$208K 0.16% 123
2025
Q3
$390K Sell
27,963
-41
-0.1% -$590 0.11% 160
2025
Q2
$420K Sell
28,004
-450
-2% -$6.43K 0.12% 156
2025
Q1
$375K Sell
28,454
-8,969
-24% -$124K 0.11% 160
2024
Q4
$590K Buy
37,423
+4,338
+13% +$65.2K 0.17% 118
2024
Q3
$525K Buy
33,085
+2,195
+7% +$35.3K 0.15% 130
2024
Q2
$470K Buy
30,890
+920
+3% +$13.2K 0.15% 116
2024
Q1
$440K Buy
29,970
+450
+2% +$6.57K 0.14% 120
2023
Q4
$411K Buy
+29,520
New +$395K 0.14% 122

Other funds holding RDY

SimplyRich's RDY Position: Q1 2026 in Review

SimplyRich increased its Dr. Reddy's Laboratories (RDY) stake by 7.7% in Q1 2026, buying an estimated $45.6K and bringing the position to 46,059 shares worth $637K. The position accounts for 0.16% of the portfolio, ranked #120.

SimplyRich first reported a position in RDY in Q4 2023 and has held it in 10 quarters since. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • SimplyRich held 46,059 shares of Dr. Reddy's Laboratories worth $637K as of Q1 2026.
  • SimplyRich bought 3,274 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $45.6K.
  • Dr. Reddy's Laboratories made up 0.16% of SimplyRich's portfolio in Q1 2026, its #120 holding.
  • SimplyRich first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 10 quarters since.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on SimplyRich's 13F filing for Q1 2026, filed 1 May 2026.